World Health Organization defends Covid-19 drug study after remdesivir maker Gilead questions methodology

//World Health Organization defends Covid-19 drug study after remdesivir maker Gilead questions methodology

World Health Organization defends Covid-19 drug study after remdesivir maker Gilead questions methodology

The World Health Organization has defended a study that sparked a debate about whether the antiviral drug remdesivir is any use in treating Covid-19.The report was based on a large-scale clinical trial of four drugs that concluded none of them helped reduce mortality or the amount of time patients spent in hospital.Gilead, the firm that makes remdesivir, has hit back at the study, questioning its methodology. “We are concerned the data from this open-label global trial has not undergone the…

Article by [author-name] (c) South China Morning Post - Read full story here.

By | 2020-10-17T11:49:24+00:00 October 17th, 2020|Headlines|Comments Off on World Health Organization defends Covid-19 drug study after remdesivir maker Gilead questions methodology